The Ensign Group, Inc. (NASDAQ:ENSG) Director Antoinette T. Hubenette sold 2,500 shares of the company’s stock in a transaction that occurred on Tuesday, September 12th. The stock was sold at an average price of $20.95, for a total transaction of $52,375.00. Following the transaction, the director now directly owns 24,626 shares of the company’s stock, valued at approximately $515,914.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shares of The Ensign Group, Inc. (NASDAQ ENSG) traded down 0.49% during trading on Friday, reaching $20.32. 433,741 shares of the company traded hands. The firm has a market capitalization of $1.03 billion, a PE ratio of 23.66 and a beta of 0.86. The firm has a 50-day moving average price of $20.43 and a 200-day moving average price of $19.85. The Ensign Group, Inc. has a 12 month low of $16.51 and a 12 month high of $23.35.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Saturday, September 30th will be paid a dividend of $0.043 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $0.17 annualized dividend and a yield of 0.85%. The Ensign Group’s dividend payout ratio is currently 20.24%.

TRADEMARK VIOLATION WARNING: This piece was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/09/16/antoinette-t-hubenette-sells-2500-shares-of-the-ensign-group-inc-ensg-stock.html.

Several brokerages recently commented on ENSG. TheStreet raised shares of The Ensign Group from a “c+” rating to a “b” rating in a research report on Monday, August 7th. Zacks Investment Research lowered shares of The Ensign Group from a “hold” rating to a “sell” rating in a research report on Tuesday, August 8th. Finally, BidaskClub lowered shares of The Ensign Group from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Three research analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $22.00.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Steinberg Global Asset Management increased its stake in The Ensign Group by 2.3% in the first quarter. Steinberg Global Asset Management now owns 77,521 shares of the company’s stock valued at $1,457,000 after purchasing an additional 1,758 shares during the period. Prudential Financial Inc. increased its stake in The Ensign Group by 5.5% in the first quarter. Prudential Financial Inc. now owns 87,592 shares of the company’s stock valued at $1,647,000 after purchasing an additional 4,600 shares during the period. Kestrel Investment Management Corp increased its stake in The Ensign Group by 89.2% in the second quarter. Kestrel Investment Management Corp now owns 352,700 shares of the company’s stock valued at $7,678,000 after purchasing an additional 166,316 shares during the period. Dimensional Fund Advisors LP increased its stake in The Ensign Group by 7.6% in the first quarter. Dimensional Fund Advisors LP now owns 2,105,058 shares of the company’s stock valued at $39,575,000 after purchasing an additional 148,627 shares during the period. Finally, Great West Life Assurance Co. Can increased its stake in The Ensign Group by 4.2% in the second quarter. Great West Life Assurance Co. Can now owns 69,276 shares of the company’s stock valued at $1,508,000 after purchasing an additional 2,800 shares during the period. Institutional investors own 84.20% of the company’s stock.

About The Ensign Group

The Ensign Group, Inc, through its operating subsidiaries, provides healthcare services across the post-acute care continuum, as well as other ancillary businesses located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Oregon, South Carolina, Texas, Utah, Washington and Wisconsin.

Insider Buying and Selling by Quarter for The Ensign Group (NASDAQ:ENSG)

Receive News & Ratings for The Ensign Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.